Interference studies with two hospital-grade and two home-grade glucose meters

Diabetes Technology and Therapeutics

Volumn 11, Issue 10, 2009, Pages 641-647

  Lyon, Martha E ^a,b,c   Baskin, Leland B ^c   Braakman, Sandy ^d   Presti, Steven ^e   Dubois, Jeffrey ^e   Shirey, Terry ^e  

^a UNIVERSITY OF CALGARY   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

^c CALGARY LABORATORY SERVICES   (Canada)

^d CALGARY HEALTH REGION   (Canada)

^e VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ASCORBIC ACID; GLUCOSE; GLUCOSE DEHYDROGENASE; GLUCOSE OXIDASE; HEXOKINASE; MALTOSE; PYRROLOQUINOLINEQUINONE;

ARTICLE; BLOOD GLUCOSE METER; BLOOD GLUCOSE MONITORING; BLOOD SAMPLING; GLUCOSE ASSAY; GLUCOSE BLOOD LEVEL; HEMATOCRIT; PRIORITY JOURNAL;

ASCORBIC ACID; BLOOD GLUCOSE; BLOOD GLUCOSE SELF-MONITORING; HEMATOCRIT; MALTOSE; NORTH AMERICA; POINT-OF-CARE SYSTEMS; QUALITY CONTROL; TIME FACTORS;

EID: 70350780199     PISSN: 15209156     EISSN: None     Source Type: Journal    
DOI: 10.1089/dia.2009.0035     Document Type: Article

References (21)

1. College of American Pathologists: Participant Summary. Northfield, IL: College of American Pathologists, 2005.
2. Dungan K, Chapman J, Braithwaite SS, Buse J: Glucose measurement: confounding issues in setting targets for inpatient management. Diabetes Care 2007;30:403-409.
3. Pidcoke HF, Wade CE, Wolf SE: Insulin and the burned patient. Crit Care Med 2007;35(9 Suppl):S524-S530.
4. Tang Z, Du X, Louie R, Kost G: Effects of drugs on glucose measurements with handheld glucose meters and a portable glucose analyzer. Am J Clin Pathol 2000;113:75-86. (Pubitemid 30217342)
5. Chance J, Li D, Jones K, Dyer K, Nichols J: Technical evaluation of five glucose meters with data management capabilities. Am J Clin Pathol 1999;111:547-556.
6. Louie R, Tang Z, Sutton D, Lee J, Kost G: Point-of-care glucose testing: effects of critical care variables, influence of reference instruments, and a modular glucose meter design. Arch Pathol Lab Med 2000;124:257-266.
7. Tang Z, Lee J, Louie R, Kost G: Effects of different hematocrit levels on glucose measurements with handheld meters for point-of-care testing. Arch Pathol Lab Med 2000;124: 1135-1140. (Pubitemid 30650312)
8. Maser RE, Butler MA, DeCherney GS: Use of arterial blood with bedside glucose reflectance meters in an intensive care unit: are they accurate? Crit Care Med 1994;22:595-599.
9. Smith EA, Kilpatrick ES: Intra-operative blood glucose measurements: the effect of haematocrit on glucose test strips. Anaesthesia 1994;49:129-132.
10. Cross MH, Brown DG: Blood glucose reagent strip tests in the operating room: influence of hematocrit, partial pressure of oxygen, and blood glucose level: a comparison of the BMtest 1-44, BM-Accutest, and Satellite G reagent strip systems. J Clin Monit 1996;12:27-33.
11. Chen E, Nichols J, Duh S, Hortin G: Performance evaluation of blood glucose monitoring devices. Diabetes Technol Ther 2003;5:749-768.
12. Khan A, Vasquez Y, Gray J, Wians F, Kroll M: The variability of results between point-of-care testing glucose meters and the central laboratory analyzer. Arch Pathol Lab Med 2006;130:1527-1532.
13. Sacks DB: Carbohydrates. In: Burtis CA, Ashwood ER, eds. Tietz Textbook of Clinical Chemistry, 3rd ed. Philadelphia: Saunders, 1999:777.
14. Winkelman JW, Wybenga DR, Tanasijevic MJ: The fiscal consequences of central vs distributed testing of glucose. Clin Chem 1994;40:1628-1630.
15. Alex CP, Manto JC, Garland JS: Clinical utility of a bedside blood analyzer for measuring blood chemistry values in neonates. J Perinatol 1998;18:45-48.
16. Boyd JC, Bruns DE: Quality specifications for glucose meters: assessment by simulation modeling of errors in insulin dose. Clin Chem 2001;47:209-214.
17. Louis PS, Ethier J: An evaluation of three glucose meter systems and their performance in relation to criteria of acceptability for neonatal specimens. Clin Chim Acta 2002; 322:139-148.
18. Biesalski HK, McGregor GP: Antioxidant therapy in critical care-is the microcirculation the primary target? Crit Care Med 2007;35(9 Suppl):S577-S583.
19. Tanaka H, Matsuda T, Miyagantani Y, Yukioka T, Matsuda H, Shimazaki S: Reduction of resuscitation fluid volumes in severely burned patients using ascorbic acid administration. Arch Surg 2000;135:326-331.
20. Institute for Safe Medication Practices: Be aware of false glucose results with point-of-care testing. ISMP Medication Safety Alert 2005;10:13.
21. Janssen W, Harff G, Caers M, Schellekens A: Positive interference of icodextrin metabolites in some enzymatic glucose methods. Clin Chem 1998;44:2379-2380.